載入...
The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
Immune-mediated inflammatory diseases (IMIDs) encompass a wide range of seemingly unrelated conditions, such as multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, asthma, chronic obstructive pulmonary disease, and systemic lupus erythematosus. Despite differing etiolog...
Na minha lista:
| 發表在: | Pharmacol Rev |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6592405/ https://ncbi.nlm.nih.gov/pubmed/31235653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/pr.117.014878 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|